0001213900-18-000044.txt : 20180102 0001213900-18-000044.hdr.sgml : 20180102 20180102170653 ACCESSION NUMBER: 0001213900-18-000044 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171229 FILED AS OF DATE: 20180102 DATE AS OF CHANGE: 20180102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TAGLICH ROBERT CENTRAL INDEX KEY: 0001353439 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54748 FILM NUMBER: 18502536 MAIL ADDRESS: STREET 1: 700 NEW YORK AVENUE CITY: HUNTINGTON STATE: NY ZIP: 11743 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Icagen, Inc. CENTRAL INDEX KEY: 0001518520 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 200982060 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4222 EMPEROR BLVD., SUITE 350 STREET 2: RESEARCH TRIANGLE PARK CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-941-5206 MAIL ADDRESS: STREET 1: 4222 EMPEROR BLVD., SUITE 350 STREET 2: RESEARCH TRIANGLE PARK CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: XRpro Sciences, Inc. DATE OF NAME CHANGE: 20141204 FORMER COMPANY: FORMER CONFORMED NAME: Caldera Pharmaceuticals Inc DATE OF NAME CHANGE: 20110419 4 1 f4122917taglichr_icagen.xml OWNERSHIP DOCUMENT X0306 4 2017-12-29 0 0001518520 Icagen, Inc. NONE 0001353439 TAGLICH ROBERT C/O ICAGEN, INC. 4222 EMPEROR BLVD., SUITE 350, RESEARCH TRIANGLE PARK DURHAM, NC 27703 1 0 1 0 Common Stock, $0.001 par value 2017-12-29 4 P 0 21429 0.37 A 72125 D Common Stock, $0.001 par value 301714 I See footnote Warrant 3.50 2017-12-29 4 A 0 5357 0.02 A 2017-12-29 2019-12-31 Common Stock 5357 5357 D Mr. Taglich indirectly owns an aggregate of 301,714 shares of common stock of Icagen, Inc. as follows: (i) 285,714 shares held in Mr. Taglich's individual retirement account; and (ii) an aggregate of 16,000 shares held by four separate custodial accounts for the benefit of Mr. Taglich's minor children. /s/ Robert Taglich 2018-01-02